Trials / Completed
CompletedNCT07058844
The Effects of a Line Dance Program on Cognitive Function, Physical Function, and Quality of Life in Older Adults With Mild Cognitive Impairment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Wanyu Shu · Academic / Other
- Sex
- Female
- Age
- 60 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the effects of a structured line dance program on cognitive function, physical performance, and quality of life in older women with mild cognitive impairment (MCI). A total of 75 participants aged 60-75 with a diagnosis of MCI will be randomly assigned to one of three groups: a high-beat-per-minute (HBLD) line dance group, a low-beat-per-minute (LBLD) line dance group, or a control group receiving no intervention. The intervention will last for 12 weeks, with sessions held three times per week for 60 minutes. Outcome measures include the Montreal Cognitive Assessment (MoCA), serum brain-derived neurotrophic factor (BDNF), physical function tests, and a quality of life questionnaire. The purpose of this study is to explore the effectiveness of non-pharmacological, rhythm-based exercise interventions for improving cognitive and physical health in older adults with cognitive decline.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | High-BPM Line Dance | A structured aerobic dance program set to music with tempos of 130-140 BPM, designed to improve cognitive and physical function in older adults with MCI. |
| BEHAVIORAL | Low-BPM Line Dance | A structured aerobic dance program set to music with tempos of 90-100 BPM, using the same choreography but slower rhythm and reduced rest intervals. |
| OTHER | Usual Daily Activity | No structured intervention will be provided. Participants will continue their routine lifestyle. |
Timeline
- Start date
- 2025-01-19
- Primary completion
- 2025-04-19
- Completion
- 2025-05-16
- First posted
- 2025-07-10
- Last updated
- 2025-07-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07058844. Inclusion in this directory is not an endorsement.